×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| UNJHA FORMULATIONS LTD. | NA | NA | NA | NA | 11.2 | 124.0 |
| GENOMIC VALLEY BIOTECH LIMITED | NA | NA | NA | NA | 11 | 44.0 |
| Cian Healthcare Limited | NA | NA | NA | NA | 10.3 |
Unjha Formulations Ltd. has established itself in the Healthcare sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.2 | 2.8 | 3.8 | 4.8 | 5.5 | 4.4 | 4.0 | 3.8 | 3.8 | 2.4 |
| Expenses | 3.3 | 3.0 | 3.6 | 4.9 | 5.1 | 4.4 | 3.2 | 3.9 | 3.5 | 2.7 |
| Operating Profit | -0.1 | -0.1 | 0.2 | -0.1 | 0.4 | 0.1 | 0.7 | -0.1 | 0.2 | -0.3 |
| OPM % | -2.74% | -4.09% | 5.59% | -2.16% | 7.38% | 1.38% | 18.22% | -2.88% | 6.3% | -12.68% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -0.1 | -0.2 | 0.2 | -0.1 | 0.4 | 0.0 | 0.7 | -0.1 | 0.2 | -0.3 |
| Tax % | 0% | 26.6% | 0% | 0% | 0% | 17400% | 0% | 0% | 0% | 0% |
| Net Profit | -0.1 | -0.2 | 0.2 | -0.1 | 0.4 | -0.2 | 0.7 | -0.1 | 0.2 | -0.4 |
| EPS in Rs | -0.21 | -0.5 | 0.4 | -0.26 | 0.87 | -0.39 | 1.56 | -0.25 | 0.5 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 6% |
| 3 Years: | 18% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 32% |
| 3 Years: | 29% |
| 1 Year: | -29% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|